Compound Detail

CHEMBL4649423

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=O)Nc1ccc(OC)cc1)=C\CC[C@@]1(C)O[C@@H]21

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL4649423
Phase	Preclinical
Structure Type	MOL
InChI Key	AUKMHLNKGDLNTB-FLRPPASCSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

425.5

MW (Da)

3.56

ALogP

HBA

HBD

101.5

PSA (Å²)

0.25

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 5 meas. best 5.54

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
HepG2 CHEMBL395	IC50	5.54	5.54	2860.0	1
BGC-823 CHEMBL614526	IC50	5.54	5.54	2900.0	1
U-87 MG CHEMBL614247	IC50	5.5	5.5	3160.0	1
HCT-116 CHEMBL394	IC50	5.37	5.37	4240.0	1
PC-9 CHEMBL614102	IC50	4.87	4.87	13600.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
HepG2	IC50	=	2860.0	nM	5.54	Antiproliferation activity against human HepG2 cells assessed as reduction in ce...	32546298
BGC-823	IC50	=	2900.0	nM	5.54	Antiproliferation activity against human BGC823 cells assessed as reduction in c...	32546298
U-87 MG	IC50	=	3160.0	nM	5.5	Antiproliferation activity against human U87MG cells assessed as reduction in ce...	32546298
HCT-116	IC50	=	4240.0	nM	5.37	Antiproliferation activity against human HCT116 cells assessed as reduction in c...	32546298
PC-9	IC50	=	13600.0	nM	4.87	Antiproliferation activity against human PC9 cells assessed as reduction in cell...	32546298

PubMed	DOI	Target Context	# Activities
32546298	10.1016/j.bmc.2020.115557	U-87 MG	1
32546298	10.1016/j.bmc.2020.115557	HCT-116	1
32546298	10.1016/j.bmc.2020.115557	HepG2	1
32546298	10.1016/j.bmc.2020.115557	BGC-823	1
32546298	10.1016/j.bmc.2020.115557	PC-9	1

Data from ChEMBL 36 via Core Engine